ARCHIVES

Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program

This article is from The Cancer Letter archive.

Vol. 06 No. 34 | August 22, 1980

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Chop Analysis Shows Program Had Major Impact In Communities

January 25, 1985

Judah Folkman, Angiogenesis Pioneer, Dead at 74.

January 18, 2008

Cancer Groups Criticize FDA For Ignoring Expert Advice.

November 24, 2000

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

February 17, 2012

NCI to Support Research and Development Of Image Guided Therapy for Prostate Cancer

July 16, 1999